Company initiates process to explore a broad range of strategic alternatives to maximize shareholder valuePITTSBURGH, Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: POAI), a science driven company ...

Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer, prostate ...

Indicators of a response to radiation therapy include pain relief and a return to baseline function or improved function. Patients may experience some relief of symptoms within a few days after ...

A research team from Memorial Sloan Kettering Cancer Center (MSK) is demonstrating that cancer outcome predictions can be ...

In the ever-evolving landscape of cancer treatment, simply removing a tumor is no longer the endpoint of care. Purple Heron ...

"The most important thing about the win is it lets scientists who are really dedicated to trying to improve the lives of ...

Thainakarin Hospital, under the leadership of Clinical Prof. Dr. Tipchart Punyaratabandhu, Hospital Director and Medical ...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today highlighted pipeline ...

30). “Insurance pre-auth is an important practical consideration in radiation oncology clinics, as it can affect timeliness of treatment and oncologic outcomes, in addition to the psychosocial ...

11月5日，进博会正式开幕。在众多展出的医疗科技行业新产品、新技术中，核医学影像成为重点关注领域之一。 会上，西门子医疗与AI医学影像企业深智透医官宣合作，将基于西门子医疗人工智能应用平台AIRC Research ...